ArticlePloS one2025
Relationship between the systemic immune-inflammatory index and overactive bladder risk: A cross-sectional assessment involving United States Adults.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07773532 (Predictive Capacity of Baseline Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index for Mirabegron Treatment Response in Women With Overactive Bladder), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Predictive Capacity of Baseline Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index for Mirabegron Treatment Response in Women With Overactive Bladder: A Prospective Cohort Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThis study aimed to evaluate the association between the systemic immune-inflammatory index (SII) and the risk of overactive bladder (OAB) in the adult United States population.
methodsData from the National Health and Nutrition Examination Survey (NHANES) 2005-2010 were analyzed. A non-pregnant cohort aged ≥20 years with available SII and OAB data was included. Weighted univariate and multivariate logistic regression analyses were performed to assess the association between SII and OAB risk. Additionally, subgroup, interaction, and restricted cubic spline analyses were conducted.
resultsA total of 4,545 participants were included, of whom 16.13% had OAB, with a mean SII of 5.75 ± 0.07. OAB risk increased with higher SII tertiles. In the fully adjusted model (Model 2), individuals in the highest SII tertile exhibited a 41% higher risk of OAB compared to those in the lowest tertile (OR: 1.41, 95% CI: 1.13-1.76, P = 0.004). Two-piece-wise regression analysis identified an SII breakpoint at 3.40, where a significant positive association was found for SII ≥ 3.40 (OR = 1.06, P < 0.0001), whereas no significant association was detected for SII < 3.40 (P = 0.06). Subgroup and interaction analyses revealed a consistent relationship between SII and OAB across different population strata, except for diabetes mellitus.
conclusionSII, an easily accessible biomarker, was independently associated with an increased risk of OAB, highlighting its potential utility in diagnostic prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.